Other News To Note
• Immunubiology Ltd., of Cambridge, UK, said the UK government-backed Biomedical Catalyst awarded the firm about £200,000 (US$300,000) to support preclinical development of pneumococcal vaccine PnuBioVax, which is designed to target a wide range of strains of bacteria.
Suite: 1100 | Atlanta, Georgia 30346, USA
Outside of the US
In the U.S. and Canada: +1-877-857-2477
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
Sign up for Highlights FREE e-mail newsletter